The journal of allergy and clinical immunology. In practice
-
J Allergy Clin Immunol Pract · Nov 2017
Randomized Controlled TrialSafety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.
The 5-grass pollen sublingual tablet has been approved for the treatment of grass pollen-induced allergic rhinoconjunctivitis in subjects with or without intermittent asthma. ⋯ The pooled analysis in 1,514 subjects from 8 clinical studies demonstrates that the 5-grass pollen sublingual tablet has a similar good safety profile in adult and pediatric patients with or without mild, intermittent asthma.